Acute severe hypothyroidism is not associated with hyponatremia even with increased water intake: A prospective study in thyroid cancer patients

BMC Endocrine Disorders

Volumn 13, Issue , 2013, Pages

  Hammami, Muhammad M ^a,b   Almogbel, Fahad ^a   Hammami, Sumaya ^a   Faifi, Jaber ^a   Alqahtani, Awad ^a   Hashem, Walid ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b ALFAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Differentiated thyroid cancer; Hyponatremia; Hypothyroidism; Radioiodine therapy

Indexed keywords

CREATININE; DIURETIC AGENT; LIOTHYRONINE; SODIUM; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CANCER PATIENT; DISEASE SEVERITY; FEMALE; FLUID INTAKE; FREE THYROXINE INDEX; HUMAN; HYPONATREMIA; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RISK FACTOR; THYROID CANCER;

EID: 84880891638     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-13-27     Document Type: Article

References (24)

1. Rose BD. Hyponatremia in hypothyroidism. UpToDate 2012, Waltham, MA: UpToDate, Basow DS.
2. Baajafer FS, Hammami MM, Mohamed GE. Prevalence and severity of hyponatremia and hypercreatininemia in short-term uncomplicated hypothyroidism. J Endocrinol Invest 1999, 22(1):35-39.
3. Montenegro J, González O, Saracho R, Aguirre R, González O, Martínez I. Changes in renal function in primary hypothyroidism. Am J Kidney Dis 1996, 27(2):195-198. 10.1016/S0272-6386(96)90539-9, 8659492.
4. Hann FW, Scanlon MF. Hyponatremia, hypothyroidism and role of arginine-vasopressin. Lancet 1997, 350(9080):755-756. 10.1016/S0140-6736(05)62563-9, 9297992.
5. Kreisman SH, Hennessy JV. Consistent reversible elevations of serum creatinine level in severe hypothyroidism. Arch Intern Med 1999, 159(1):79-82. 10.1001/archinte.159.1.79, 9892334.
6. Schmitz PH, de Meijer PH, Meinder AE. Hyponatremia due to hypothyroidism: a pure renal mechanism. Neth J Med 2001, 58(3):143-149. 10.1016/S0300-2977(01)00081-X, 11246114.
7. Soh EY, Clark OH. Surgical considerations and approach to thyroid cancer. Endocrinol Metab Clin North Am 1996, 25(1):115-139. 10.1016/S0889-8529(05)70315-7, 8907683.
8. Sawka AM, Thephamongkhol K, Brouwers M, Thabane L, Browman G, Gerstein HC. A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer. J Clin Endocrinol Metab 2004, 89(8):3668-3676. 10.1210/jc.2003-031167, 15292285.
9. Woodrum DT, Gauger PG. Role of 131I in the treatment of well differentiated thyroid cancer. J Surg Oncol 2005, 89(3):114-121. 10.1002/jso.20185, 15719384.
10. Liel Y. Preparation for radioactive iodine administration in differentiated thyroid cancer patients. Clin Endocrinol (Oxf) 2002, 57(4):523-527.
11. Pan M, Tan T, Guan C. Evaluation of side-effects after 131I-therapy for differentiated thyroid carcinoma. Hua Xi Yi Ke Da Xue Xue Bao 2000, 31(2):197-199.
12. Shakir MK, Krook LS, Schraml FV, Hays JH, Clyde PW. Symptomatic hyponatremia in association with a low-iodine diet and levothyroxine withdrawal prior to I131 in patients with metastatic thyroid carcinoma. Thyroid 2008, 18(7):787-792. 10.1089/thy.2008.0050, 18631009.
13. Krishnamurthy VR, McDougall IR. Severe hyponatremia: a danger of low-iodine diet. Thyroid 2007, 17(9):889-892. 10.1089/thy.2007.0094, 17822373.
14. Sari R, Sevinc A. Life-threatening hyponatremia due to cessation of L-thyroxine. J Natl Med Assoc 2003, 95(10):991-994. 2594489, 14620714.
15. Warner MH, Holding S, Kilpatrick E. The effect of newly diagnosed hypothyroidism on serum sodium concentrations: a retrospective study. Clin Endocrinol (Oxf) 2006, 64(5):598-599.
16. Grikiniene J, Volbekas V, Stakisaitis D. Gender differences of sodium metabolism and hyponatremia as an adverse drug effect. Medicina (Kaunas) 2004, 40(10):935-942.
17. Hawkins RC. Age and gender as risk factors for hyponatremia and hypernatremia. Clin Chim Acta 2003, 337(1-2):169-172.
18. Juul KV, Klein BM, Sandström R, Erichsen L, Nørgaard JP. Gender difference in antidiuretic response to desmopressin. Am J Physiol Renal Physiol 2011, 300(5):F1116-F1122. 10.1152/ajprenal.00741.2010, 21367921.
19. Liu J, Sharma N, Zheng W, Ji H, Tam H, Wu X, Manigrasso MB, Sandberg K, Verbalis JG. Sex differences in vasopressin V2 receptor expression and vasopressin-induced antidiuresis. Am J Physiol Renal Physiol 2011, 300(2):F433-F440. 10.1152/ajprenal.00199.2010, 3044003, 21123493.
20. Kuz GM, Manssourin A. Carbamazepine-induced hyponatremia:assessment of risk factors. Ann Pharmacother 2005, 39:1943-1946. 10.1345/aph.1G209, 16189283.
21. Chow KM, Szeto CC, Wong TYH, Leung CB, Li PKT. Risk factors for thiazide-induced hyponatremia. Q J Med 2003, 96:911-917.
22. Skowsky WR, Kikuchi TA. The role of vasopressin in the impaired water excretion of myxedema. Am J Med 1987, 64:613-621.
23. Iwasaki Y, Oiso Y, Yamauchi K, Takatsuki K, Kondo K, Hasegwa H, Tomita A. Osmoregulation of plasma vasopressin in myxedema. J Clin Endocrinol Metab 1990, 70:534-539. 10.1210/jcem-70-2-534, 2298864.
24. Derubertis FR, Michelis MF, Bloom ME, Mintz DH, Field JB, Davis BB. Impaired water excretion in myxedema. Am J Med 1971, 51(1):41-53. 10.1016/0002-9343(71)90322-6, 5570319.